Table 1.
Response | Glucose mg/dL (mmol/L) |
---|---|
Inhibition of endogenous insulin secretion | 83 (4.6) |
Counterregulatory hormone release (glucagon, epinephrine) | 68 (3.8) |
Onset of autonomic and neuroglycopenic symptoms | 58–50 (3.2–2.8) |
Neurophysiologic dysfunction, evoked responses | 54–43 (3.0–2.4) |
Widespread electroencephalographic changes | 54 (3.0) |
Cognitive dysfunction, inability to perform complex tasks | 50 (2.8) |
Severe neuroglycopenia, reduced conscious level, seizures, coma | 27 (< 1.5) |
Data from Zammitt and Frier[15]